Funder
Anhui Provincial Natural Science Foundation
Anhui Provincial science and technology key project
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference87 articles.
1. Balighi K, Daneshpazhooh M, Aghazadeh N, Hejazi P, Aryanian Z, Azizpour A, et al. Pemphigus vulgaris-associated Kaposi’s sarcoma: response to paclitaxel and review of the literature. Eur Acad Dermatol Venereol. 2014;28(8):987–94.
2. Tauchi Y, Kashiwagi S, Ishihara S, Asano Y, Sakimura C, Kurata K, et al. Clinical experience of nab-Paclitaxel treatment in 31 patients with breast cancer. Gan to kagaku ryoho. 2014;41(12):1948–50.
3. Robinson WR, Davis N, Rogers AS. Paclitaxel maintenance chemotherapy following intraperitoneal chemotherapy for ovarian cancer. Int J Gynecol Cancer. 2008;18(5):891–5.
4. Horinouchi H, Yamamoto N, Nokihara H, Horai T, Nishio M, Ohyanagi F, et al. A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC). Cancer Chemother Pharmacol. 2014;74(1):37–43.
5. Jimenez B, Trigo JM, Pajares BI, Saez MI, Quero C, Navarro V, et al. Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients. Oral Oncol. 2013;49(2):182–5.
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献